Loading…
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer
Highlights • Lip-DOPE-P5-MPL (DMPC/DMPG/Chol/DOPE/P5/MPL) is an effective peptide-based HER2/neu vaccine formulation. • Lip-DOPE-P5-MPL induces high IFN-γ production by CD8+ T cells intracellularly. • Lip-DOPE-P5-MPL induces CTL response leading to tumor growth inhibition. • Lip-DOPE-P5-MPL caused t...
Saved in:
Published in: | Cancer letters 2014-12, Vol.355 (1), p.54-60 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights • Lip-DOPE-P5-MPL (DMPC/DMPG/Chol/DOPE/P5/MPL) is an effective peptide-based HER2/neu vaccine formulation. • Lip-DOPE-P5-MPL induces high IFN-γ production by CD8+ T cells intracellularly. • Lip-DOPE-P5-MPL induces CTL response leading to tumor growth inhibition. • Lip-DOPE-P5-MPL caused the lowest tumor size and the longest survival time in mice model of TUBO tumor. |
---|---|
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/j.canlet.2014.09.016 |